| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 BRIP1 WAPL MYO1C MYO10 ABCB5 DNAH2 BTAF1 ABCC6 STARD9 SHOC1 UBA6 XRCC6 RAD54L DNAH11 | 5.98e-05 | 614 | 167 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.11e-05 | 118 | 167 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYO1C MYO10 CD2AP CLASP2 PFN1 EEF2 DST ANLN CLMN DIAPH1 TNS1 | 2.03e-04 | 479 | 167 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.79e-04 | 38 | 167 | 4 | GO:0000146 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP251 ANK3 CLASP1 GTSE1 DNAH2 LCA5L CLASP2 TACC2 CEP192 SPECC1L CEP128 FSIP2 MET DST STARD9 DIAPH1 CCDC68 CEP295 CKAP2 DNAAF1 PCM1 RHOT1 ZMYND12 DNAH11 | 4.27e-06 | 1058 | 166 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | CLASP1 CLASP2 TACC2 CEP192 SPECC1L MET DIAPH1 CEP295 CKAP2 DNAAF1 RHOT1 DNAH11 | 4.69e-06 | 293 | 166 | 12 | GO:0032886 |
| GeneOntologyBiologicalProcess | cell cycle process | MIIP BRIP1 WAPL ANK3 CLASP1 RBBP8 GTSE1 CLASP2 TACC2 E4F1 CEP192 CDK14 USP19 MSX2 MET BRDT CCNB3 ANLN STARD9 MKI67 SHOC1 CEP295 PRKDC CKAP2 BUB3 PCM1 RAD54L PROX1 | 1.18e-05 | 1441 | 166 | 28 | GO:0022402 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.65e-05 | 100 | 166 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | VPS11 WAPL WASHC2C MYO1C CLASP1 CARMIL1 CD2AP CLIC4 CLASP2 CEP192 SPECC1L PFN1 WASHC2A C2CD5 MSX2 MET EFNB1 TBC1D22A MKI67 DIAPH1 CEP295 CKAP2 BUB3 CLEC16A RHOT1 PROX1 | 2.67e-05 | 1342 | 166 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | microtubule anchoring | 4.49e-05 | 25 | 166 | 4 | GO:0034453 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP251 ANK3 DNAH2 LCA5L CEP128 FSIP2 MET DST STARD9 DNAAF1 PCM1 RHOT1 ZMYND12 DNAH11 | 4.74e-05 | 493 | 166 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | WASHC2C MYO1C CLASP1 CARMIL1 CD2AP CLIC4 CLASP2 SPECC1L PFN1 WASHC2A MET DIAPH1 CEP295 CKAP2 PROX1 | 7.15e-05 | 579 | 166 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ANK3 CLASP1 DNAH2 CLASP2 TACC2 CEP192 SPECC1L FSIP2 MET DST STARD9 CCDC68 CEP295 CKAP2 DNAAF1 PCM1 ZMYND12 | 7.34e-05 | 720 | 166 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 8.31e-05 | 89 | 166 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | organelle assembly | VPS11 MOSPD2 CLASP1 CEP162 DNAH2 CLASP2 CEP192 CEP128 FSIP2 MRPS7 NRXN3 EFNB1 ANLN TBC1D22A STARD9 CEP295 PRKDC DNAAF1 HPS5 PCM1 ZMYND12 PROX1 | 1.22e-04 | 1138 | 166 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | BRIP1 RBBP8 CLASP2 MSX2 H1-8 BRDT CCNB3 MKI67 SHOC1 BUB3 RAD54L | 1.30e-04 | 350 | 166 | 11 | GO:0051321 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | WAPL WASHC2C CLASP1 CARMIL1 CLASP2 CEP192 SPECC1L PFN1 MET CKAP2 BUB3 CLEC16A | 1.61e-04 | 421 | 166 | 12 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.68e-04 | 144 | 166 | 7 | GO:0043244 | |
| GeneOntologyBiologicalProcess | positive regulation of protein polymerization | 1.77e-04 | 102 | 166 | 6 | GO:0032273 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 1.80e-04 | 194 | 166 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 2.00e-04 | 197 | 166 | 8 | GO:1902904 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.07e-04 | 105 | 166 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | MAG WAPL WASHC2C ANK3 CLASP1 CARMIL1 MBP CLASP2 CEP192 SPECC1L PFN1 TTC3 MET DNAJC15 DIAPH1 CKAP2 BUB3 CLEC16A | 2.15e-04 | 864 | 166 | 18 | GO:0051129 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | WASHC2C MYO1C CLASP1 CARMIL1 CD2AP CLASP2 SPECC1L PFN1 WASHC2A RYR2 MET PROX1 | 2.32e-04 | 438 | 166 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 2.41e-04 | 38 | 166 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 2.62e-04 | 205 | 166 | 8 | GO:0051495 | |
| GeneOntologyBiologicalProcess | nuclear division | BRIP1 WAPL CLASP1 CLASP2 CEP192 MSX2 MET BRDT ANLN MKI67 SHOC1 BUB3 RAD54L | 2.67e-04 | 512 | 166 | 13 | GO:0000280 |
| GeneOntologyBiologicalProcess | negative regulation of stress fiber assembly | 2.67e-04 | 39 | 166 | 4 | GO:0051497 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | WASHC2C MYO1C CLASP1 CARMIL1 CD2AP CLASP2 SPECC1L PFN1 WASHC2A MET PROX1 | 2.90e-04 | 384 | 166 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 3.57e-04 | 42 | 166 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | nuclear protein quality control by the ubiquitin-proteasome system | 3.82e-04 | 4 | 166 | 2 | GO:0071630 | |
| GeneOntologyBiologicalProcess | negative regulation of barbed-end actin filament capping | 3.82e-04 | 4 | 166 | 2 | GO:2000813 | |
| GeneOntologyBiologicalProcess | protein polymerization | WASHC2C MYO1C CLASP1 CARMIL1 CD2AP CLASP2 CEP192 PFN1 MET DIAPH1 | 3.88e-04 | 334 | 166 | 10 | GO:0051258 |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 4.65e-04 | 122 | 166 | 6 | GO:0110020 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament bundle assembly | 4.66e-04 | 45 | 166 | 4 | GO:0032232 | |
| GeneOntologyBiologicalProcess | cell division | CDCA3 BRIP1 WAPL ANK3 CLASP1 RBBP8 CD2AP CLASP2 E4F1 SPECC1L CDK14 CCNB3 ANLN CKAP2 BUB3 | 5.26e-04 | 697 | 166 | 15 | GO:0051301 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | MIIP WAPL ANK3 CLASP1 RBBP8 GTSE1 CLASP2 TACC2 CEP192 CDK14 MET CCNB3 ANLN MKI67 PRKDC CKAP2 BUB3 | 5.43e-04 | 854 | 166 | 17 | GO:1903047 |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 6.34e-04 | 5 | 166 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 6.34e-04 | 5 | 166 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 6.34e-04 | 5 | 166 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 6.34e-04 | 5 | 166 | 2 | GO:2001197 | |
| GeneOntologyCellularComponent | cell cortex | MYH2 MYO1C CLASP1 MYO10 CD2AP CLASP2 PFN1 C2CD5 DST ANLN NR3C2 | 2.03e-04 | 371 | 167 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | ruffle membrane | 2.32e-04 | 108 | 167 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | filamentous actin | 2.35e-04 | 38 | 167 | 4 | GO:0031941 | |
| GeneOntologyCellularComponent | ruffle | 2.58e-04 | 206 | 167 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 3.74e-04 | 18 | 167 | 3 | GO:0120212 | |
| GeneOntologyCellularComponent | microtubule organizing center | CLASP1 CEP162 CD2AP CLIC4 CLASP2 TACC2 CEP192 SPECC1L CEP128 C2CD5 CCNB3 STARD9 DIAPH1 CCDC68 CEP295 NUP93 CKAP2 PCM1 | 4.14e-04 | 919 | 167 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | centriole | 4.75e-04 | 172 | 167 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 6.24e-04 | 5 | 167 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 6.24e-04 | 5 | 167 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | cytoplasmic region | CFAP251 CLASP1 CEP162 DNAH2 LCA5L CLASP2 DST NR3C2 DNAAF1 DNAH11 | 6.56e-04 | 360 | 167 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 VPS11 ACACA MYO1C MYO10 CARMIL1 CD2AP CLIC4 SPECC1L DST ANLN DIAPH1 | 7.54e-04 | 576 | 167 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | A band | 7.89e-04 | 52 | 167 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | actin filament | 1.15e-03 | 146 | 167 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | myosin complex | 1.27e-03 | 59 | 167 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | basal cortex | 1.30e-03 | 7 | 167 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 1.30e-03 | 7 | 167 | 2 | GO:0005958 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 1.30e-03 | 7 | 167 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | centrosome | CLASP1 CEP162 CD2AP CLIC4 CLASP2 TACC2 CEP192 CEP128 C2CD5 CCNB3 DIAPH1 CEP295 NUP93 CKAP2 PCM1 | 1.34e-03 | 770 | 167 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule plus-end | 1.42e-03 | 28 | 167 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 1.44e-03 | 61 | 167 | 4 | GO:0101003 | |
| GeneOntologyCellularComponent | spindle | WAPL CLASP1 CEP162 CLASP2 E4F1 SPECC1L CEP128 DIAPH1 CEP295 CKAP2 DNAAF1 | 1.46e-03 | 471 | 167 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 2.20e-03 | 9 | 167 | 2 | GO:0070419 | |
| GeneOntologyCellularComponent | cell leading edge | ATN1 MYO1C MYO10 CARMIL1 CD2AP PSD3 CLASP2 C2CD5 DST DIAPH1 PSD4 | 2.33e-03 | 500 | 167 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 2.74e-03 | 10 | 167 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH2 VPS11 ANK3 MYO1C CLASP1 CEP162 CARMIL1 CD2AP GTSE1 DNAH2 CLASP2 SPECC1L RYR2 DST DIAPH1 CEP295 CKAP2 DNAH11 | 2.83e-03 | 1179 | 167 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH2 VPS11 ANK3 MYO1C CLASP1 CEP162 CARMIL1 CD2AP GTSE1 DNAH2 CLASP2 SPECC1L RYR2 DST DIAPH1 CEP295 CKAP2 DNAH11 | 3.04e-03 | 1187 | 167 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 3.33e-03 | 11 | 167 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 3.33e-03 | 11 | 167 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 3.33e-03 | 11 | 167 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 3.33e-03 | 11 | 167 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | microtubule end | 3.44e-03 | 38 | 167 | 3 | GO:1990752 | |
| Domain | HEAT | 5.04e-05 | 48 | 157 | 5 | PF02985 | |
| Domain | FAM21 | 7.02e-05 | 2 | 157 | 2 | IPR027308 | |
| Domain | HEAT | 1.26e-04 | 58 | 157 | 5 | IPR000357 | |
| Domain | CAP-ZIP_m | 2.09e-04 | 3 | 157 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 2.09e-04 | 3 | 157 | 2 | IPR029341 | |
| Domain | Myosin_head_motor_dom | 2.84e-04 | 38 | 157 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.84e-04 | 38 | 157 | 4 | PS51456 | |
| Domain | Myosin_head | 2.84e-04 | 38 | 157 | 4 | PF00063 | |
| Domain | MYSc | 2.84e-04 | 38 | 157 | 4 | SM00242 | |
| Domain | HEAT_REPEAT | 3.07e-04 | 70 | 157 | 5 | PS50077 | |
| Domain | Tensin_PTB | 4.17e-04 | 4 | 157 | 2 | IPR033929 | |
| Domain | CLASP_N | 4.17e-04 | 4 | 157 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 4.17e-04 | 4 | 157 | 2 | IPR024395 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MIIP RALGAPA1 EHBP1 NAA15 ACACA CLASP1 CEP162 CARMIL1 CD2AP GTSE1 PSD3 CLASP2 CEP192 CDK14 FSIP2 PTPN14 DST ANLN CLMN STARD9 CCDC138 PLEKHA5 BOD1L1 NR3C2 NUP93 CRYBG3 CKAP2 PCM1 DOP1B VCPIP1 | 2.54e-17 | 861 | 169 | 30 | 36931259 |
| Pubmed | CDCA3 AFF2 ACACA ANK3 MYO1C CEP162 LIN54 GPATCH1 MUC16 CLASP2 CEP192 SPECC1L PFN1 USP19 RYR2 CEMIP2 MET EEF2 ZC3H11A DST EFNB1 UBR5 MKI67 ZFHX3 PRKDC SPEN CLEC16A PCM1 | 1.40e-16 | 777 | 169 | 28 | 35844135 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 BRIP1 WAPL WASHC2C ATN1 ACACA MYO1C CLASP1 RBBP8 CARMIL1 GTSE1 BTAF1 USP19 C2CD5 EEF2 ZC3H11A TAF3 ANLN MKI67 UTP20 PRKDC BUB3 SPEN XRCC6 PCM1 NUP153 VCPIP1 | 1.14e-15 | 774 | 169 | 27 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 EHBP1 ACACA ANK3 CARMIL1 CD2AP MBP CLASP2 BTAF1 CEP192 CDK14 TTC3 NBPF1 ZC3H11A ZNF608 TBC1D22A CLMN RALGPS1 ARID5B UBA6 ZFHX3 BOD1L1 ALCAM QSER1 CKAP2 CSMD1 HPS5 CLEC16A ADGRD1 PCM1 | 3.54e-11 | 1489 | 169 | 30 | 28611215 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 WAPL ACACA MYO1C RPN2 THUMPD3 NOL11 CLASP2 PFN1 TTC3 TOE1 USP19 EEF2 ZC3H11A AP2A2 STARD9 SERPINB12 MKI67 DIAPH1 UBA6 UTP20 BOD1L1 PRKDC NUP93 BUB3 SPEN FKBP3 XRCC6 NUP153 | 6.21e-11 | 1425 | 169 | 29 | 30948266 |
| Pubmed | RALGAPA1 BRIP1 WAPL MOSPD2 CLASP1 CLASP2 WASHC2A CEMIP2 NBAS ANLN TBC1D22A CLMN DIAPH1 SECISBP2 PLEKHA5 BOD1L1 CEP295 QSER1 CKAP2 PCM1 VCPIP1 | 8.38e-11 | 733 | 169 | 21 | 34672954 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 NAA15 MYO1C RPN2 CD109 NOL11 SPECC1L PFN1 TOE1 MRPS7 EEF2 ZC3H11A PTPN14 DST ANLN SERPINB12 MKI67 UTP20 PLEKHA5 PRKDC NUP93 CKAP2 BUB3 SPEN FKBP3 XRCC6 NUP153 | 9.41e-11 | 1257 | 169 | 27 | 36526897 |
| Pubmed | EPRS1 USP45 WAPL WASHC2C ANK3 CEP162 CD2AP NOL11 CLASP2 TACC2 CEP192 TTC3 WASHC2A C2CD5 ZC3H11A ANLN CLMN ARID5B DIAPH1 BOD1L1 CEP295 QSER1 CKAP2 TNS1 NUP153 | 1.16e-10 | 1084 | 169 | 25 | 11544199 | |
| Pubmed | RALGAPA1 CDCA3 MOSPD2 NAA15 ANK3 RPN2 PSD3 NOL11 CLASP2 CEP192 TTC3 WASHC2A CEMIP2 C2CD5 MRPS7 MET NBAS PTPN14 EFNB1 UBR5 CLMN DNAJC15 CCDC138 UBA6 PLEKHA5 CRYBG3 CKAP2 XRCC6 PCM1 | 1.68e-10 | 1487 | 169 | 29 | 33957083 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 EPRS1 WAPL NAA15 WASHC2C ACACA CARMIL1 GPATCH1 TACC2 BTAF1 PFN1 ZC3H11A DST CLMN MKI67 BOD1L1 PRKDC CKAP2 FKBP3 XRCC6 PCM1 NUP153 VCPIP1 | 1.95e-10 | 934 | 169 | 23 | 33916271 |
| Pubmed | EPRS1 WAPL ACACA ANK3 CD2AP SPECC1L ZC3H11A TAF3 PTPN14 ANLN PLEKHA5 BOD1L1 PRKDC QSER1 BUB3 SPEN PCM1 VCPIP1 | 2.41e-10 | 549 | 169 | 18 | 38280479 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | WAPL NAA15 WASHC2C CLASP1 CARMIL1 LIN54 CD2AP CLASP2 TACC2 CEP192 PFN1 WASHC2A MRPS7 NBAS FANCB SERPINB5 UBR5 ANLN SERPINB12 MKI67 PRKDC NUP93 XRCC6 PCM1 NUP153 | 4.31e-10 | 1155 | 169 | 25 | 20360068 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 WAPL NAA15 ACACA MYO1C THUMPD3 NOL11 CLIC4 PFN1 TOE1 MRPS7 EEF2 ZC3H11A PTPN14 DST AP2A2 UBR5 ANLN SERPINB12 MKI67 DIAPH1 UTP20 PLEKHA5 PRKDC NUP93 BUB3 XRCC6 | 4.74e-10 | 1353 | 169 | 27 | 29467282 |
| Pubmed | ACACA CLASP1 CLASP2 CEP192 WASHC2A DST UBR5 CCDC138 PLEKHA5 CRYBG3 PCM1 VCPIP1 | 5.37e-10 | 209 | 169 | 12 | 36779422 | |
| Pubmed | RALGAPA1 CLASP1 CEP162 CLASP2 CEP192 C2CD5 PTPN14 DST AP2A2 UBR5 TBC1D22A CCDC138 PLEKHA5 CEP295 PRKDC PCM1 | 6.95e-10 | 446 | 169 | 16 | 24255178 | |
| Pubmed | WASHC2C CLASP1 MYO10 PSD3 CEP192 WASHC2A USP19 ZC3H11A UBR5 STARD9 BOD1L1 SPEN CLEC16A DOP1B VCPIP1 | 1.68e-09 | 407 | 169 | 15 | 12693553 | |
| Pubmed | RALGAPA1 EHBP1 EPRS1 ANK3 RPN2 CARMIL1 CD2AP PSD3 PFN1 EEF2 DST UBA6 PLEKHA5 BOD1L1 PRKDC CRYBG3 XRCC6 NUP153 VCPIP1 | 2.06e-09 | 708 | 169 | 19 | 39231216 | |
| Pubmed | EHBP1 ACACA RBBP8 LIN54 CD2AP DST ZNF608 UBR5 ARID5B PLEKHA5 ZFHX3 CRYBG3 PCM1 VCPIP1 PROX1 | 2.42e-09 | 418 | 169 | 15 | 34709266 | |
| Pubmed | VPS11 WASHC2C ANK3 THUMPD3 WASHC2A CEP128 NBAS PTPN14 CCDC138 PLEKHA5 CKAP2 PCM1 | 4.29e-09 | 251 | 169 | 12 | 29778605 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | EPRS1 ACACA MYO1C RPN2 BTAF1 SPECC1L PARP14 NBAS UTP20 PRKDC XRCC6 | 5.01e-09 | 202 | 169 | 11 | 33005030 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | WASHC2C CLASP1 RBBP8 LIN54 TACC2 CEP192 PFN1 WASHC2A PTPN14 UBR5 ARID5B DIAPH1 SECISBP2 CRYBG3 SPEN PCM1 VCPIP1 | 5.11e-09 | 588 | 169 | 17 | 38580884 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 BRIP1 WAPL LIN54 GPATCH1 CD2AP GTSE1 NOL11 EEF2 ZC3H11A TAF3 ANLN MKI67 BOD1L1 PRKDC QSER1 SPEN FKBP3 XRCC6 PCM1 NUP153 | 9.11e-09 | 954 | 169 | 21 | 36373674 |
| Pubmed | RALGAPA1 EPRS1 MYH1 WAPL NAA15 WASHC2C MYO1C MYO10 CARMIL1 EEF2 DST UBR5 MKI67 DIAPH1 FRMPD3 XRCC6 | 9.97e-09 | 538 | 169 | 16 | 28524877 | |
| Pubmed | PSD3 DST AP2A2 ZNF608 UBR5 PLEKHA5 HPS5 CLEC16A UNC80 ZNF286A DOP1B | 1.53e-08 | 225 | 169 | 11 | 12168954 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAG RALGAPA1 CDCA3 EHBP1 CARMIL1 MBP PSD3 PARP14 CDK14 CEMIP2 MET PTPN14 EFNB1 PLEKHA5 ALCAM PSD4 | 2.17e-08 | 569 | 169 | 16 | 30639242 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 MYH1 MXRA5 ACACA DNAH2 LCA5L REV3L PFN1 PARP14 FREM2 DST ARID5B UTP20 BOD1L1 CEP295 PRKDC XRCC6 DOP1B | 2.33e-08 | 736 | 169 | 18 | 29676528 |
| Pubmed | EPRS1 MYH1 MYH2 ELOA2 MYO1C RPN2 RBBP8 ABCB5 LIN54 DNAH2 TTC3 CEP128 RYR2 EEF2 NRXN3 DST AP2A2 ZNF608 STARD9 BOD1L1 CEP295 ALCAM PRKDC SPEN XRCC6 | 3.60e-08 | 1442 | 169 | 25 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | WASHC2C ACACA CEP162 CARMIL1 GPATCH1 CD2AP GTSE1 CEP192 WASHC2A CEP128 PTPN14 UBR5 CCDC138 CEP295 NUP93 CKAP2 CLEC16A PCM1 VCPIP1 | 4.06e-08 | 853 | 169 | 19 | 28718761 |
| Pubmed | RALGAPA1 CDCA3 MOSPD2 ANK3 MYO1C RPN2 CEP162 PSD3 TNS2 CLASP2 CEP192 CEMIP2 PTPN14 KLHL15 CCDC138 MKI67 NUP93 CRYBG3 CKAP2 TNS1 NUP153 | 4.60e-08 | 1049 | 169 | 21 | 27880917 | |
| Pubmed | ANK3 CLASP1 CLASP2 SPECC1L TTC3 EEF2 DST AP2A2 UBR5 DIAPH1 UBA6 PLEKHA5 QSER1 FRMPD3 BUB3 TNS1 XRCC6 PCM1 NUP153 PROX1 | 5.46e-08 | 963 | 169 | 20 | 28671696 | |
| Pubmed | MYO1C CLASP1 MYO10 GTSE1 MBP CLASP2 PFN1 EEF2 SERPINB5 ZC3H11A DST SECISBP2 CKAP2 BUB3 FKBP3 XRCC6 PCM1 | 1.02e-07 | 723 | 169 | 17 | 34133714 | |
| Pubmed | NID2 WAPL ATN1 MYO1C REV3L C2CD5 TAF3 PTPN14 ZNF608 BRDT UBR5 CCNB3 DIAPH1 ZFHX3 CEP295 CRYBG3 CSMD1 UNC80 PCM1 RHOT1 PROX1 | 1.29e-07 | 1116 | 169 | 21 | 31753913 | |
| Pubmed | NAA15 ACACA MYO1C RPN2 NOL11 ZC3H11A DST UBR5 MKI67 UTP20 PRKDC NUP93 SPEN XRCC6 PCM1 NUP153 | 1.42e-07 | 653 | 169 | 16 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 GTSE1 NOL11 BTAF1 SPECC1L PFN1 ZC3H11A DST EFNB1 UBR5 SERPINB12 MKI67 UBA6 UTP20 PRKDC NUP93 SPEN XRCC6 PCM1 NUP153 | 1.46e-07 | 1024 | 169 | 20 | 24711643 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | WAPL GPATCH1 NOL11 ZC3H11A MKI67 ZFHX3 BOD1L1 PRKDC SPEN XRCC6 NUP153 | 1.58e-07 | 283 | 169 | 11 | 30585729 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.69e-07 | 123 | 169 | 8 | 26912792 | |
| Pubmed | EPRS1 MOSPD2 NAA15 MYO1C CLASP1 RPN2 GTSE1 CLASP2 PFN1 PARP14 NBAS EEF2 UBR5 MKI67 PLEKHA5 PRKDC NUP93 XRCC6 PCM1 RHOT1 PSD4 | 2.74e-07 | 1168 | 169 | 21 | 19946888 | |
| Pubmed | 3.56e-07 | 57 | 169 | 6 | 29089450 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CDCA3 EHBP1 ANK3 PSD3 CEMIP2 C2CD5 PTPN14 DST EFNB1 ANLN PLEKHA5 ALCAM | 3.66e-07 | 377 | 169 | 12 | 38117590 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RALGAPA1 WAPL ACACA MYO1C RPN2 NOL11 CLIC4 PFN1 TOE1 EEF2 ZC3H11A ANLN MKI67 UTP20 BOD1L1 PRKDC BUB3 XRCC6 NUP153 | 3.94e-07 | 989 | 169 | 19 | 36424410 |
| Pubmed | 4.41e-07 | 191 | 169 | 9 | 31177093 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 20150414 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 AFF2 ACACA ANK3 MYO1C RPN2 PFN1 NBAS EEF2 DST AP2A2 DIAPH1 ZFHX3 PRKDC BUB3 FKBP3 XRCC6 | 4.75e-07 | 807 | 169 | 17 | 30575818 |
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 31806049 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 32386572 | ||
| Pubmed | BRIP1 ANK3 RBBP8 CLIC4 SPECC1L SERPINB5 PTPN14 DST AP2A2 UBR5 MKI67 BUB3 XRCC6 PCM1 NUP153 | 5.53e-07 | 634 | 169 | 15 | 34591612 | |
| Pubmed | MYH2 MXRA5 ELOA2 DNAH2 MUC16 REV3L ABCC6 RYR2 MRPS7 SERPINB5 ARID5B CEP295 DNAAF1 SPEN DNAH11 | 5.98e-07 | 638 | 169 | 15 | 31182584 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 6.62e-07 | 101 | 169 | 7 | 24613305 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 ACACA MYO1C RPN2 SPECC1L PFN1 EEF2 DST ZNF804B PRKDC NUP93 XRCC6 PCM1 | 6.82e-07 | 477 | 169 | 13 | 31300519 |
| Pubmed | CDCA3 EHBP1 ANK3 PTPN14 MKI67 SECISBP2 PLEKHA5 CRYBG3 NUP153 VCPIP1 | 7.18e-07 | 263 | 169 | 10 | 34702444 | |
| Pubmed | EPRS1 ACACA GPATCH1 CEP192 PFN1 EEF2 ZC3H11A MKI67 BUB3 XRCC6 PCM1 | 7.25e-07 | 330 | 169 | 11 | 32529326 | |
| Pubmed | EPRS1 WAPL NAA15 ATN1 RPN2 BTAF1 CEMIP2 FREM2 DST PLEKHA5 QSER1 CRYBG3 HPS5 CLEC16A RHOT1 | 7.54e-07 | 650 | 169 | 15 | 38777146 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 MYO1C MYO10 GTSE1 CD109 SPECC1L PFN1 TOE1 EEF2 DST AP2A2 SERPINB12 MKI67 UTP20 PRKDC NUP93 BUB3 XRCC6 | 9.73e-07 | 949 | 169 | 18 | 36574265 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CDCA3 EHBP1 MOSPD2 NAA15 ATN1 MYO1C THUMPD3 NOL11 TACC2 TTC3 USP19 MRPS7 NBAS PTPN14 DST CLMN CCDC138 SECISBP2 CRYBG3 CKAP2 XRCC6 RHOT1 VCPIP1 | 1.08e-06 | 1496 | 169 | 23 | 32877691 |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 30257991 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 NAA15 ACACA CLASP1 RPN2 CARMIL1 CLASP2 TACC2 PFN1 TOE1 MRPS7 EEF2 AP2A2 UBR5 DNAJC15 DIAPH1 UBA6 PRKDC BUB3 FKBP3 XRCC6 VCPIP1 | 1.58e-06 | 1415 | 169 | 22 | 28515276 |
| Pubmed | EPRS1 MYO1C CD2AP BTAF1 MET DST ANLN PLEKHA5 PRKDC NUP93 PROX1 | 1.69e-06 | 360 | 169 | 11 | 33111431 | |
| Pubmed | EPRS1 NAA15 CLASP1 LIN54 EEF2 ZC3H11A UBR5 ANLN MKI67 PRKDC NUP93 QSER1 BUB3 SPEN FKBP3 XRCC6 PCM1 NUP153 ZNF286A | 1.98e-06 | 1103 | 169 | 19 | 34189442 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 20417199 | ||
| Pubmed | 2.24e-06 | 121 | 169 | 7 | 22412018 | ||
| Pubmed | WAPL NOL11 EEF2 SERPINB5 ZC3H11A TAF3 UBR5 MKI67 DIAPH1 UBA6 BOD1L1 PRKDC NUP93 QSER1 BUB3 FKBP3 XRCC6 NUP153 | 2.47e-06 | 1014 | 169 | 18 | 32416067 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | WASHC2C RPN2 MYO10 CARMIL1 RFTN2 MYRFL PFN1 CDK14 WASHC2A TMC3 AP2A2 BRDT TBC1D22A SECISBP2 CSMD1 FKBP3 GIMAP6 ADGRD1 RHOT1 DOP1B | 2.90e-06 | 1242 | 169 | 20 | 30973865 |
| Pubmed | EPRS1 NAA15 ACACA RPN2 NOL11 CLASP2 USP19 EEF2 DIAPH1 PRKDC NUP93 BUB3 XRCC6 NUP153 | 3.20e-06 | 638 | 169 | 14 | 33239621 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NAA15 ACACA MYO1C CLASP1 RPN2 LIN54 CD2AP CLIC4 PFN1 USP19 EEF2 SERPINB5 ZC3H11A ANLN SERPINB12 UBA6 ALCAM PRKDC NUP93 FKBP3 XRCC6 | 3.35e-06 | 1367 | 169 | 21 | 32687490 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.56e-06 | 184 | 169 | 8 | 32908313 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 NAA15 ACACA ANK3 CD2AP CLIC4 CLASP2 PFN1 MRPS7 EEF2 DST AP2A2 UBR5 DIAPH1 PRKDC NUP93 FKBP3 XRCC6 NUP153 | 3.57e-06 | 1149 | 169 | 19 | 35446349 |
| Pubmed | CDCA3 BRIP1 CLASP1 GTSE1 CLIC4 WASHC2A DST ANLN SERPINB12 PLEKHA5 CRYBG3 FKBP3 | 3.78e-06 | 472 | 169 | 12 | 38943005 | |
| Pubmed | Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex. | 3.89e-06 | 7 | 169 | 3 | 12145306 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 32817053 | ||
| Pubmed | MYH1 MYH2 ANK3 MYO1C RPN2 MUC16 PFN1 EEF2 DST AP2A2 BRDT SERPINB12 MKI67 PRKDC BUB3 XRCC6 | 4.05e-06 | 844 | 169 | 16 | 25963833 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | CDCA3 EHBP1 ANK3 CARMIL1 CD2AP PFN1 CEMIP2 EEF2 DST ANLN CLMN PLEKHA5 VCPIP1 | 4.38e-06 | 565 | 169 | 13 | 25468996 |
| Pubmed | 4.53e-06 | 50 | 169 | 5 | 37001908 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.94e-06 | 256 | 169 | 9 | 33397691 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | MYO1C RPN2 TNS2 SPECC1L PFN1 MET UBR5 KLHL15 MKI67 PRKDC NUP93 XRCC6 DOP1B | 5.09e-06 | 573 | 169 | 13 | 28330616 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 RPN2 LIN54 GPATCH1 NOL11 E4F1 ZC3H11A DST ARID5B MKI67 UTP20 PRKDC NUP93 QSER1 CKAP2 BUB3 SPEN XRCC6 NUP153 VCPIP1 | 5.33e-06 | 1294 | 169 | 20 | 30804502 |
| Pubmed | 5.74e-06 | 332 | 169 | 10 | 37433992 | ||
| Pubmed | EPRS1 BRIP1 NAA15 NOL11 PFN1 EEF2 MKI67 DIAPH1 NUP93 BUB3 XRCC6 NUP153 | 5.99e-06 | 494 | 169 | 12 | 26831064 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 29946151 | ||
| Pubmed | Development of the adult neurogenic niche in the hippocampus of mice. | 6.20e-06 | 8 | 169 | 3 | 25999820 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 6.58e-06 | 200 | 169 | 8 | 35546148 | |
| Pubmed | MAG RALGAPA1 EPRS1 ANK3 MYO1C CLASP1 CARMIL1 MBP PSD3 CLASP2 SPECC1L PFN1 EEF2 DST AP2A2 CLMN PLEKHA5 TNS1 PCM1 RHOT1 DNAH11 | 6.75e-06 | 1431 | 169 | 21 | 37142655 | |
| Pubmed | NID2 ANK3 E4F1 TTC3 RYR2 DST AP2A2 UBR5 DIAPH1 UBA6 SECISBP2 XRCC6 VCPIP1 | 7.09e-06 | 591 | 169 | 13 | 15231748 | |
| Pubmed | EPRS1 WASHC2C GTSE1 TACC2 EEF2 ZC3H11A ANLN MKI67 PLEKHA5 SPEN PCM1 NUP153 | 7.19e-06 | 503 | 169 | 12 | 16964243 | |
| Pubmed | EHBP1 ACACA ANK3 CARMIL1 PSD3 CEMIP2 C2CD5 MET PTPN14 DST PLEKHA5 | 7.50e-06 | 421 | 169 | 11 | 36976175 | |
| Pubmed | 7.77e-06 | 146 | 169 | 7 | 21399614 | ||
| Pubmed | 8.12e-06 | 147 | 169 | 7 | 29576527 | ||
| Pubmed | 8.87e-06 | 149 | 169 | 7 | 25184681 | ||
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 38960088 | ||
| Pubmed | 9.84e-06 | 100 | 169 | 6 | 10048485 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | BRIP1 ACACA GPATCH1 EEF2 UBR5 SERPINB12 MKI67 PRKDC BUB3 NUP153 | 1.08e-05 | 357 | 169 | 10 | 37059091 |
| Pubmed | 1.11e-05 | 215 | 169 | 8 | 35973513 | ||
| Pubmed | 1.12e-05 | 60 | 169 | 5 | 20682791 | ||
| Pubmed | 1.16e-05 | 29 | 169 | 4 | 37160119 | ||
| Pubmed | RALGAPA1 WAPL CEP162 CDK14 CEMIP2 NRXN3 DST ZNF608 RALGPS1 PLEKHA5 NUP93 HPS5 | 1.19e-05 | 529 | 169 | 12 | 14621295 | |
| Pubmed | 1.20e-05 | 156 | 169 | 7 | 37108203 | ||
| Pubmed | EHBP1 EPRS1 NAA15 WASHC2C ACACA ANK3 PSD3 TACC2 WASHC2A RYR2 MRPS7 MET SERPINB5 AP2A2 CRYBG3 CLEC16A PCM1 VCPIP1 | 1.21e-05 | 1139 | 169 | 18 | 36417873 | |
| Pubmed | Neural cell adhesion molecule is required for ventricular conduction system development. | 1.32e-05 | 10 | 169 | 3 | 34100064 | |
| Pubmed | Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle. | 1.32e-05 | 10 | 169 | 3 | 29679560 | |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 1.32e-05 | 62 | 169 | 5 | 26508657 | |
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 15203215 | ||
| Interaction | NUP43 interactions | BRIP1 ATN1 ACACA RBBP8 LIN54 GPATCH1 NOL11 CCDC168 RYR2 FSIP2 TAF3 DST ZNF608 UBR5 MKI67 UTP20 ZFHX3 BOD1L1 NUP93 HPS5 SPEN NUP153 | 7.96e-09 | 625 | 164 | 22 | int:NUP43 |
| Interaction | YWHAH interactions | MIIP RALGAPA1 EHBP1 CLASP1 CEP162 CARMIL1 CD2AP GTSE1 PSD3 TNS2 CLASP2 CEP192 SPECC1L CDK14 CEP128 PTPN14 DST ANLN CLMN STARD9 CCDC138 PLEKHA5 BOD1L1 NR3C2 CRYBG3 CLEC16A PCM1 DOP1B VCPIP1 | 1.94e-08 | 1102 | 164 | 29 | int:YWHAH |
| Interaction | C11orf52 interactions | CDCA3 EHBP1 ANK3 MYO1C CARMIL1 PSD3 CEMIP2 C2CD5 MET PTPN14 DST EFNB1 PLEKHA5 ALCAM NUP93 | 4.00e-08 | 311 | 164 | 15 | int:C11orf52 |
| Interaction | MAPRE1 interactions | CLASP1 MYO10 CEP162 CD2AP GTSE1 CD109 CLASP2 TACC2 SPECC1L MEOX2 MRPS7 DST CCDC138 DIAPH1 PLEKHA5 NUP93 CKAP2 PCM1 NUP153 | 4.20e-08 | 514 | 164 | 19 | int:MAPRE1 |
| Interaction | NIN interactions | CLASP1 CEP162 GPATCH1 GTSE1 CLASP2 CEP192 CEP128 ANLN CCDC138 CCDC68 CEP295 NUP93 CKAP2 PCM1 VCPIP1 | 2.58e-07 | 359 | 164 | 15 | int:NIN |
| Interaction | CNTRL interactions | NAA15 CLASP1 CEP162 GPATCH1 GTSE1 CEP192 WASHC2A CEP128 CCDC138 CKAP2 PCM1 | 5.37e-07 | 193 | 164 | 11 | int:CNTRL |
| Interaction | KCNA3 interactions | RALGAPA1 EHBP1 EPRS1 AFF2 ANK3 MYO1C RPN2 CARMIL1 CD2AP PSD3 SPECC1L PFN1 EEF2 DST UBA6 PLEKHA5 BOD1L1 PRKDC CRYBG3 SPEN XRCC6 NUP153 VCPIP1 | 6.43e-07 | 871 | 164 | 23 | int:KCNA3 |
| Interaction | DYNLT1 interactions | WAPL ACACA CLASP1 LIN54 CLASP2 DST CCDC68 UBA6 PLEKHA5 CKAP2 SPEN NUP153 | 6.86e-07 | 241 | 164 | 12 | int:DYNLT1 |
| Interaction | LRRC31 interactions | EPRS1 ACACA MYO1C RPN2 BTAF1 SPECC1L PARP14 NBAS UTP20 PRKDC XRCC6 | 9.75e-07 | 205 | 164 | 11 | int:LRRC31 |
| Interaction | SMC5 interactions | EPRS1 MYH1 BRIP1 WAPL ACACA LIN54 GPATCH1 CD2AP GTSE1 NOL11 REV3L EEF2 ZC3H11A TAF3 ANLN MKI67 BOD1L1 PRKDC QSER1 SPEN FKBP3 XRCC6 PCM1 NUP153 | 1.94e-06 | 1000 | 164 | 24 | int:SMC5 |
| Interaction | CEP120 interactions | 2.49e-06 | 106 | 164 | 8 | int:CEP120 | |
| Interaction | CPAP interactions | ATN1 CLASP1 GPATCH1 CLASP2 CEP192 WASHC2A CCDC138 CKAP2 PCM1 VCPIP1 | 2.49e-06 | 182 | 164 | 10 | int:CPAP |
| Interaction | MAPRE3 interactions | CLASP1 CEP162 GTSE1 CLASP2 TACC2 SPECC1L MEOX2 DST SECISBP2 PLEKHA5 CKAP2 | 2.99e-06 | 230 | 164 | 11 | int:MAPRE3 |
| Interaction | HDAC1 interactions | EHBP1 MYH1 MYH2 ACACA RBBP8 CD2AP E4F1 CEP128 USP19 MSX2 SERPINB5 DST ZNF608 UBR5 ANLN ARID5B MKI67 PLEKHA5 ZFHX3 CRYBG3 BUB3 SPEN FKBP3 PCM1 VCPIP1 | 3.47e-06 | 1108 | 164 | 25 | int:HDAC1 |
| Interaction | CEP43 interactions | CARMIL1 GPATCH1 SPECC1L TTC3 CEP128 CCDC138 CEP295 CRYBG3 HPS5 PCM1 | 3.66e-06 | 190 | 164 | 10 | int:CEP43 |
| Interaction | ANKRD28 interactions | ANK3 CEP162 CEP192 PFN1 CEP128 MRPS7 AP2A2 UBR5 PRKDC CLEC16A XRCC6 | 3.68e-06 | 235 | 164 | 11 | int:ANKRD28 |
| Interaction | SPICE1 interactions | CLASP1 CEP162 GTSE1 CEP128 CCDC138 SECISBP2 PLEKHA5 CEP295 CKAP2 PCM1 | 3.83e-06 | 191 | 164 | 10 | int:SPICE1 |
| Interaction | TRIM37 interactions | MYH2 ELOA2 MYO1C RPN2 GTSE1 CEP192 PFN1 CEP128 EEF2 ZC3H11A UBR5 MKI67 PRKDC FAM124B SPEN XRCC6 PCM1 VCPIP1 | 3.99e-06 | 630 | 164 | 18 | int:TRIM37 |
| Interaction | STX6 interactions | RALGAPA1 CDCA3 EHBP1 VPS11 WASHC2C ANK3 CARMIL1 WASHC2A CEMIP2 MEOX2 NBAS DST AP2A2 PLEKHA5 CRYBG3 | 4.07e-06 | 448 | 164 | 15 | int:STX6 |
| Interaction | NAA40 interactions | EHBP1 EPRS1 WAPL NAA15 WASHC2C ACACA CARMIL1 GPATCH1 TACC2 BTAF1 PFN1 ZC3H11A DST CLMN MKI67 BOD1L1 PRKDC CKAP2 FKBP3 XRCC6 PCM1 NUP153 VCPIP1 | 4.55e-06 | 978 | 164 | 23 | int:NAA40 |
| Interaction | KIF2A interactions | CLASP1 GTSE1 CEP192 PFN1 PTPN14 BRDT UBR5 ANLN PLEKHA5 CKAP2 CLEC16A | 4.88e-06 | 242 | 164 | 11 | int:KIF2A |
| Interaction | BICD1 interactions | ACACA CARMIL1 GPATCH1 CEP192 CEP128 PTPN14 UBR5 ANLN CCDC138 PCM1 VCPIP1 | 6.65e-06 | 250 | 164 | 11 | int:BICD1 |
| Interaction | CDC42 interactions | RALGAPA1 CDCA3 EHBP1 EPRS1 MOSPD2 NAA15 ACACA ANK3 MYO1C RPN2 CARMIL1 GTSE1 PSD3 CEMIP2 C2CD5 PTPN14 EFNB1 AP2A2 ANLN MKI67 DIAPH1 UTP20 PLEKHA5 PRKDC QSER1 FKBP3 PCM1 | 8.66e-06 | 1323 | 164 | 27 | int:CDC42 |
| Interaction | YWHAG interactions | MIIP RALGAPA1 EHBP1 NAA15 CLASP1 CEP162 CARMIL1 CD2AP GTSE1 PSD3 TNS2 CLASP2 CEP192 SPECC1L CDK14 PTPN14 DST ANLN CLMN STARD9 PLEKHA5 BOD1L1 PRKDC CKAP2 PCM1 PSD4 | 9.07e-06 | 1248 | 164 | 26 | int:YWHAG |
| Interaction | MEN1 interactions | EPRS1 WAPL WASHC2C ATN1 MYO1C RBBP8 GPATCH1 NOL11 BTAF1 PARP14 TOE1 ZC3H11A ZNF608 UBR5 ANLN MKI67 UTP20 BOD1L1 NUP93 QSER1 BUB3 SPEN NUP153 | 1.04e-05 | 1029 | 164 | 23 | int:MEN1 |
| Interaction | PPIA interactions | CDCA3 BRIP1 WASHC2C ANK3 CLASP1 GTSE1 CLIC4 WASHC2A EEF2 TAF3 DST ANLN STARD9 SERPINB12 KLHL15 MKI67 PLEKHA5 CRYBG3 FKBP3 XRCC6 NUP153 | 1.13e-05 | 888 | 164 | 21 | int:PPIA |
| Interaction | DVL2 interactions | ELOA2 ATN1 ACACA MYO10 REV3L CEP128 NBAS EEF2 AP2A2 ARID5B DIAPH1 PLEKHA5 BUB3 XRCC6 ADGRD1 DNAH11 | 1.32e-05 | 557 | 164 | 16 | int:DVL2 |
| Interaction | NR3C1 interactions | MYH2 MXRA5 ELOA2 RPN2 CD2AP DNAH2 MUC16 REV3L ABCC6 RYR2 MSX2 MRPS7 SERPINB5 ANLN ARID5B CEP295 NR3C2 PRKDC DNAAF1 SPEN NUP153 DNAH11 | 1.40e-05 | 974 | 164 | 22 | int:NR3C1 |
| Interaction | SFN interactions | MIIP RALGAPA1 CLASP1 CEP162 CARMIL1 CD2AP CLASP2 CEP192 MET SERPINB5 PTPN14 DST ANLN CLMN PLEKHA5 NUP93 CRYBG3 VCPIP1 | 1.43e-05 | 692 | 164 | 18 | int:SFN |
| Interaction | CEP152 interactions | 1.64e-05 | 179 | 164 | 9 | int:CEP152 | |
| Interaction | CDH1 interactions | CDCA3 EHBP1 ANK3 CARMIL1 CD2AP PFN1 CEMIP2 MET EEF2 PTPN14 DST ZNF608 ANLN CLMN MKI67 DIAPH1 PLEKHA5 PRKDC VCPIP1 | 1.65e-05 | 768 | 164 | 19 | int:CDH1 |
| Interaction | STK3 interactions | 1.79e-05 | 181 | 164 | 9 | int:STK3 | |
| Interaction | UNC45A interactions | MYO1C CEP162 CEP128 USP19 MEOX2 ANLN MKI67 DIAPH1 PRKDC CLEC16A | 1.81e-05 | 228 | 164 | 10 | int:UNC45A |
| Interaction | TRIM36 interactions | 2.39e-05 | 144 | 164 | 8 | int:TRIM36 | |
| Interaction | AURKC interactions | 2.52e-05 | 43 | 164 | 5 | int:AURKC | |
| Interaction | RAB9A interactions | RALGAPA1 CDCA3 EHBP1 VPS11 WASHC2C WASHC2A CEMIP2 NBAS DST EFNB1 CLMN PLEKHA5 ALCAM NUP93 CRYBG3 DOP1B | 2.96e-05 | 595 | 164 | 16 | int:RAB9A |
| Interaction | YWHAQ interactions | MIIP RALGAPA1 MYH2 ACACA CLASP1 CEP162 GTSE1 PSD3 CLASP2 CEP192 SPECC1L PFN1 CDK14 TH EEF2 PTPN14 DST EFNB1 ANLN STARD9 PLEKHA5 PRKDC PCM1 | 3.85e-05 | 1118 | 164 | 23 | int:YWHAQ |
| Interaction | RNF123 interactions | EPRS1 MYH1 MXRA5 ACACA DNAH2 LCA5L REV3L PFN1 PARP14 USP19 FREM2 DST ARID5B UTP20 BOD1L1 CEP295 PRKDC XRCC6 DOP1B | 4.30e-05 | 824 | 164 | 19 | int:RNF123 |
| Interaction | PMS2 interactions | 4.84e-05 | 80 | 164 | 6 | int:PMS2 | |
| Interaction | SASS6 interactions | 4.85e-05 | 159 | 164 | 8 | int:SASS6 | |
| Interaction | PCM1 interactions | CEP162 GPATCH1 LCA5L NOL11 CEP192 TTC3 CEP128 CCDC138 SECISBP2 CEP295 CKAP2 CCDC183 PCM1 | 5.78e-05 | 434 | 164 | 13 | int:PCM1 |
| Interaction | DIRAS3 interactions | RALGAPA1 CDCA3 ANK3 PSD3 CEMIP2 MEOX2 DST EFNB1 PLEKHA5 ALCAM | 5.90e-05 | 262 | 164 | 10 | int:DIRAS3 |
| Interaction | ARL16 interactions | 5.96e-05 | 83 | 164 | 6 | int:ARL16 | |
| Interaction | TLE3 interactions | MYH1 MYH2 BRIP1 ATN1 ANK3 RBBP8 GPATCH1 ZNF608 UBR5 ARID5B ZFHX3 SPEN | 6.15e-05 | 376 | 164 | 12 | int:TLE3 |
| Interaction | RYK interactions | 6.17e-05 | 212 | 164 | 9 | int:RYK | |
| Interaction | KIZ interactions | 6.41e-05 | 27 | 164 | 4 | int:KIZ | |
| Interaction | YWHAZ interactions | MIIP RALGAPA1 CLASP1 CEP162 MBP PSD3 NOL11 CLIC4 CLASP2 TACC2 CEP192 CDK14 FSIP2 MSX2 TH PTPN14 DST ANLN STARD9 SERPINB12 PLEKHA5 TNS1 XRCC6 PCM1 PSD4 | 6.56e-05 | 1319 | 164 | 25 | int:YWHAZ |
| Interaction | RHOT2 interactions | CDCA3 EHBP1 TACC2 BTAF1 EEF2 DST ANLN SECISBP2 CRYBG3 CLEC16A RHOT1 | 6.66e-05 | 321 | 164 | 11 | int:RHOT2 |
| Interaction | WRAP73 interactions | 6.69e-05 | 123 | 164 | 7 | int:WRAP73 | |
| Interaction | KRT8 interactions | MYH1 CLASP1 CEP162 CEP192 TTC3 PTPN14 ANLN ZNF804B CCDC138 PLEKHA5 NUP93 CRYBG3 XRCC6 | 6.79e-05 | 441 | 164 | 13 | int:KRT8 |
| Interaction | XRCC6 interactions | WAPL NAA15 RBBP8 LIN54 GPATCH1 NOL11 PFN1 MSX2 EEF2 ZC3H11A ANLN MKI67 DIAPH1 ZFHX3 BOD1L1 PRKDC SPEN CLEC16A XRCC6 NUP153 | 6.84e-05 | 928 | 164 | 20 | int:XRCC6 |
| Interaction | CKAP5 interactions | WAPL CLASP1 RPN2 CEP162 CLASP2 TACC2 TTC3 CEP128 USP19 EFNB1 ANLN | 6.85e-05 | 322 | 164 | 11 | int:CKAP5 |
| Interaction | ATG16L1 interactions | CDCA3 ACACA ANK3 CLASP2 CCDC168 CEP192 SPECC1L PFN1 PARP14 TOE1 RYR2 NBAS EEF2 ZC3H11A PTPN14 ANLN SECISBP2 NUP93 CRYBG3 FKBP3 XRCC6 PCM1 PSD4 | 6.85e-05 | 1161 | 164 | 23 | int:ATG16L1 |
| Interaction | CEP162 interactions | 7.16e-05 | 168 | 164 | 8 | int:CEP162 | |
| Interaction | RAB35 interactions | RALGAPA1 CDCA3 EHBP1 ANK3 MYO1C CARMIL1 PSD3 CEMIP2 C2CD5 PTPN14 DST EFNB1 DIAPH1 PLEKHA5 ALCAM | 7.17e-05 | 573 | 164 | 15 | int:RAB35 |
| Interaction | CENPK interactions | 8.28e-05 | 88 | 164 | 6 | int:CENPK | |
| Interaction | CCDC14 interactions | 9.05e-05 | 129 | 164 | 7 | int:CCDC14 | |
| Interaction | CCDC8 interactions | EPRS1 GTSE1 BTAF1 SPECC1L DST EFNB1 UBR5 SERPINB12 ARID5B MKI67 UBA6 UTP20 PRKDC NUP93 XRCC6 PCM1 | 9.37e-05 | 656 | 164 | 16 | int:CCDC8 |
| Interaction | NINL interactions | CEP162 GPATCH1 GTSE1 CEP192 CEP128 UBR5 CCDC138 ZFHX3 CEP295 PRKDC CKAP2 PCM1 VCPIP1 | 9.93e-05 | 458 | 164 | 13 | int:NINL |
| Interaction | CTDSPL interactions | 1.06e-04 | 92 | 164 | 6 | int:CTDSPL | |
| Interaction | GSK3A interactions | ACACA CLASP1 CLASP2 CEP192 WASHC2A DST UBR5 CCDC138 PLEKHA5 PRKDC CRYBG3 PCM1 VCPIP1 | 1.13e-04 | 464 | 164 | 13 | int:GSK3A |
| Interaction | GOLGA1 interactions | 1.30e-04 | 183 | 164 | 8 | int:GOLGA1 | |
| Interaction | TXLNA interactions | 1.40e-04 | 236 | 164 | 9 | int:TXLNA | |
| Interaction | UVRAG interactions | 1.42e-04 | 97 | 164 | 6 | int:UVRAG | |
| Interaction | HOOK1 interactions | 1.58e-04 | 240 | 164 | 9 | int:HOOK1 | |
| Interaction | RAC3 interactions | RALGAPA1 CDCA3 EHBP1 MOSPD2 MYO10 CARMIL1 PSD3 PFN1 CEMIP2 C2CD5 EFNB1 DIAPH1 UTP20 PLEKHA5 ALCAM | 1.68e-04 | 619 | 164 | 15 | int:RAC3 |
| Interaction | ROCK1 interactions | 1.81e-04 | 192 | 164 | 8 | int:ROCK1 | |
| Interaction | DLST interactions | EPRS1 NAA15 MYO1C RPN2 PFN1 EEF2 ANLN DNAJC15 UBA6 PRKDC NUP93 HPS5 XRCC6 | 1.93e-04 | 490 | 164 | 13 | int:DLST |
| Interaction | TNFRSF1B interactions | 1.96e-04 | 146 | 164 | 7 | int:TNFRSF1B | |
| Interaction | CEP89 interactions | 2.04e-04 | 147 | 164 | 7 | int:CEP89 | |
| Interaction | RCOR1 interactions | EHBP1 ACACA RBBP8 CD2AP DST UBR5 ARID5B MKI67 PLEKHA5 ZFHX3 SPEN PCM1 VCPIP1 | 2.09e-04 | 494 | 164 | 13 | int:RCOR1 |
| Interaction | PLEKHG1 interactions | 2.16e-04 | 67 | 164 | 5 | int:PLEKHG1 | |
| Interaction | MYO3A interactions | 2.24e-04 | 15 | 164 | 3 | int:MYO3A | |
| Interaction | VPS33B interactions | 2.30e-04 | 199 | 164 | 8 | int:VPS33B | |
| Interaction | UBA6 interactions | 2.31e-04 | 150 | 164 | 7 | int:UBA6 | |
| Interaction | WDR5 interactions | EPRS1 NAA15 ATN1 ACACA MYO1C RPN2 NOL11 PARP14 MEOX2 MRPS7 EEF2 ZNF608 UBR5 ANLN DIAPH1 BOD1L1 PRKDC BUB3 TNS1 FKBP3 XRCC6 | 2.44e-04 | 1101 | 164 | 21 | int:WDR5 |
| Interaction | HERC2 interactions | CEP162 GTSE1 SPECC1L TTC3 USP19 DST CKAP2 BUB3 HPS5 CLEC16A PCM1 NUP153 ZNF286A | 2.49e-04 | 503 | 164 | 13 | int:HERC2 |
| Interaction | SLX4 interactions | USP45 BRIP1 ACACA GPATCH1 GTSE1 REV3L EEF2 AP2A2 UBR5 SERPINB12 MKI67 PRKDC BUB3 NUP153 | 2.51e-04 | 572 | 164 | 14 | int:SLX4 |
| Interaction | HOOK3 interactions | 2.55e-04 | 202 | 164 | 8 | int:HOOK3 | |
| Interaction | GSK3B interactions | ACACA MYO1C CLASP1 CLASP2 CEP192 PFN1 WASHC2A MET EEF2 DST UBR5 CCDC138 MKI67 PLEKHA5 PRKDC CRYBG3 PCM1 VCPIP1 | 2.58e-04 | 868 | 164 | 18 | int:GSK3B |
| Interaction | RHOQ interactions | RALGAPA1 CDCA3 EHBP1 CARMIL1 PSD3 PFN1 CEMIP2 C2CD5 DST EFNB1 AP2A2 PLEKHA5 | 2.77e-04 | 442 | 164 | 12 | int:RHOQ |
| Interaction | FBXO42 interactions | 2.79e-04 | 259 | 164 | 9 | int:FBXO42 | |
| Interaction | PFN1 interactions | CARMIL1 CEP192 PFN1 NBAS ANLN DIAPH1 PLEKHA5 BOD1L1 CRYBG3 FKBP3 XRCC6 DOP1B VCPIP1 | 2.79e-04 | 509 | 164 | 13 | int:PFN1 |
| Interaction | TRIM66 interactions | 2.82e-04 | 205 | 164 | 8 | int:TRIM66 | |
| Interaction | SYNE3 interactions | RPN2 GPATCH1 CEP192 CEP128 NBAS PTPN14 DST CLMN CCDC138 SECISBP2 CEP295 CRYBG3 | 2.89e-04 | 444 | 164 | 12 | int:SYNE3 |
| Interaction | RHOA interactions | RALGAPA1 CDCA3 EHBP1 MOSPD2 ANK3 RPN2 PFN1 TOE1 CEMIP2 C2CD5 SERPINB5 PTPN14 EFNB1 AP2A2 ANLN MKI67 DIAPH1 UTP20 PLEKHA5 PRKDC QSER1 CLEC16A | 2.96e-04 | 1199 | 164 | 22 | int:RHOA |
| Interaction | KIAA0753 interactions | 3.05e-04 | 157 | 164 | 7 | int:KIAA0753 | |
| Interaction | ODF2 interactions | 3.17e-04 | 158 | 164 | 7 | int:ODF2 | |
| Interaction | C10orf88 interactions | 3.27e-04 | 113 | 164 | 6 | int:C10orf88 | |
| Interaction | THOC1 interactions | 3.31e-04 | 210 | 164 | 8 | int:THOC1 | |
| Interaction | SUMO2 interactions | EPRS1 WAPL WASHC2C PFN1 EEF2 ZC3H11A DST ANLN MKI67 BOD1L1 PRKDC FKBP3 XRCC6 NUP153 | 3.49e-04 | 591 | 164 | 14 | int:SUMO2 |
| Interaction | STYK1 interactions | 3.55e-04 | 161 | 164 | 7 | int:STYK1 | |
| Interaction | RAB4A interactions | RALGAPA1 CDCA3 EHBP1 WASHC2C CD2AP CLIC4 WASHC2A CEMIP2 DST EFNB1 PLEKHA5 DOP1B | 3.75e-04 | 457 | 164 | 12 | int:RAB4A |
| Interaction | SIRT7 interactions | NAA15 ACACA MYO1C RPN2 NOL11 ZC3H11A DST UBR5 MKI67 UTP20 PRKDC NUP93 SPEN XRCC6 PCM1 NUP153 | 3.87e-04 | 744 | 164 | 16 | int:SIRT7 |
| Interaction | RNF41 interactions | 3.97e-04 | 164 | 164 | 7 | int:RNF41 | |
| Interaction | CEP135 interactions | MIIP WASHC2C CEP162 GPATCH1 CEP192 CEP128 CCDC138 CEP295 PCM1 | 3.99e-04 | 272 | 164 | 9 | int:CEP135 |
| Interaction | PHLPP1 interactions | 4.12e-04 | 333 | 164 | 10 | int:PHLPP1 | |
| Interaction | MARCKS interactions | CDCA3 EHBP1 ANK3 RPN2 PSD3 PFN1 CEMIP2 MSX2 PTPN14 EFNB1 ANLN PLEKHA5 FKBP3 XRCC6 | 4.13e-04 | 601 | 164 | 14 | int:MARCKS |
| Interaction | LCK interactions | CDCA3 ANK3 MYO1C CARMIL1 MBP PSD3 MET EEF2 PTPN14 DST PLEKHA5 CRYBG3 | 4.21e-04 | 463 | 164 | 12 | int:LCK |
| Interaction | HECTD1 interactions | EPRS1 ACACA CLASP1 GPATCH1 NOL11 TACC2 PFN1 MRPS7 EEF2 ZC3H11A PTPN14 MKI67 UTP20 PRKDC NUP93 CKAP2 BUB3 FKBP3 XRCC6 | 4.23e-04 | 984 | 164 | 19 | int:HECTD1 |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 2.82e-04 | 5 | 97 | 2 | 902 | |
| GeneFamily | WASH complex | 4.21e-04 | 6 | 97 | 2 | 1331 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 7.81e-04 | 8 | 97 | 2 | 837 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.50e-04 | 206 | 97 | 6 | 682 | |
| GeneFamily | Serpin peptidase inhibitors | 1.02e-03 | 37 | 97 | 3 | 739 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.44e-03 | 50 | 97 | 3 | 1293 | |
| GeneFamily | Myosin heavy chains | 2.86e-03 | 15 | 97 | 2 | 1098 | |
| GeneFamily | Dyneins, axonemal | 3.68e-03 | 17 | 97 | 2 | 536 | |
| GeneFamily | DNA helicases | 3.68e-03 | 17 | 97 | 2 | 1167 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.08e-03 | 20 | 97 | 2 | 548 | |
| GeneFamily | Zinc fingers MYND-type | 5.60e-03 | 21 | 97 | 2 | 87 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 WAPL CLASP1 MYO10 CD2AP PSD3 CLASP2 BTAF1 SPECC1L REV3L C2CD5 NBAS DST UBR5 ARID5B UTP20 ZFHX3 ALCAM CRYBG3 SPEN CLEC16A NUP153 DOP1B | 6.84e-09 | 856 | 168 | 23 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EHBP1 WAPL CLASP1 MYO10 CD2AP CLASP2 SPECC1L REV3L C2CD5 DST UBR5 ARID5B SPEN CLEC16A NUP153 DOP1B | 5.99e-08 | 466 | 168 | 16 | M13522 |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 4.63e-07 | 191 | 168 | 10 | M2148 | |
| Coexpression | SHEPARD_BMYB_TARGETS | 5.91e-07 | 76 | 168 | 7 | M15973 | |
| Coexpression | FISCHER_DREAM_TARGETS | MIIP CDCA3 EHBP1 BRIP1 NAA15 ACACA LIN54 GTSE1 CLIC4 CEP192 TOE1 FANCB ANLN MKI67 CEP295 PRKDC NUP93 CKAP2 BUB3 NUP153 RAD54L | 1.13e-06 | 969 | 168 | 21 | M149 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ZDHHC2 EHBP1 BRIP1 GTSE1 REV3L TTC3 C2CD5 TH ANLN RALGPS1 CCDC138 MKI67 CKAP2 XRCC6 PCM1 RAD54L PROX1 | 1.94e-06 | 680 | 168 | 17 | MM456 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 2.14e-06 | 176 | 168 | 9 | M2981 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 4.01e-06 | 190 | 168 | 9 | M761 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP | 5.61e-06 | 198 | 168 | 9 | M8041 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 9.63e-06 | 268 | 168 | 10 | M45796 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.75e-05 | 126 | 168 | 7 | M39132 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.49e-05 | 183 | 168 | 8 | M2993 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.54e-05 | 300 | 168 | 10 | M8702 | |
| Coexpression | DE_YY1_TARGETS_DN | 3.05e-05 | 93 | 168 | 6 | M3278 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_NPCS | 3.77e-05 | 142 | 168 | 7 | M39078 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP | 4.21e-05 | 197 | 168 | 8 | M7930 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | CDCA3 BRIP1 WAPL GTSE1 MUC16 MKI67 UBA6 PRKDC QSER1 CKAP2 BUB3 RAD54L | 4.25e-05 | 458 | 168 | 12 | M8520 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | EPRS1 RPN2 GTSE1 NOL11 MRPS7 MKI67 UTP20 PRKDC NUP93 BUB3 XRCC6 PCM1 NUP153 DOP1B | 4.29e-05 | 612 | 168 | 14 | M4772 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | CDCA3 GTSE1 CEMIP2 FANCB FREM2 ANLN MKI67 PLEKHA5 ZFHX3 CKAP2 | 4.62e-05 | 322 | 168 | 10 | M39060 |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 4.68e-05 | 200 | 168 | 8 | M3580 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 5.02e-05 | 202 | 168 | 8 | M11840 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 6.71e-05 | 107 | 168 | 6 | M39165 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ZDHHC2 EHBP1 MOSPD2 ANK3 LIN54 MBP CEP192 RFTN2 CEP128 FANCB DST SLC15A2 TBC1D22A CLMN RALGPS1 ZFHX3 CEP295 ALCAM TNS1 | 8.83e-05 | 1102 | 168 | 19 | M2369 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | ATN1 RBBP8 CD2AP GTSE1 BTAF1 UBR5 MKI67 PRKDC NUP93 BUB3 RAD54L | 1.01e-04 | 426 | 168 | 11 | M9516 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ZDHHC2 EHBP1 MOSPD2 ANK3 LIN54 MBP CEP192 RFTN2 CEP128 FANCB DST SLC15A2 TBC1D22A CLMN RALGPS1 ZFHX3 CEP295 ALCAM TNS1 | 1.14e-04 | 1124 | 168 | 19 | MM1070 |
| Coexpression | LEIN_OLIGODENDROCYTE_MARKERS | 1.30e-04 | 76 | 168 | 5 | M1714 | |
| Coexpression | LEIN_OLIGODENDROCYTE_MARKERS | 1.39e-04 | 77 | 168 | 5 | MM716 | |
| Coexpression | CHANGOLKAR_H2AFY_TARGETS_DN | 1.51e-04 | 42 | 168 | 4 | M2290 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | CDCA3 NID2 RBBP8 LIN54 GTSE1 MBP CEP192 FANCB NRXN3 EFNB1 ANLN CLMN MKI67 ALCAM CRYBG3 HPS5 TNS1 RAD54L | 1.54e-04 | 1054 | 168 | 18 | M45798 |
| Coexpression | ZHONG_PFC_C1_OPC | 1.57e-04 | 238 | 168 | 8 | M39096 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.62e-04 | 179 | 168 | 7 | M39308 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | EPRS1 MYH1 AFF2 ANK3 RPN2 MYO10 RBBP8 MBP USP19 MSX2 EFNB1 MKI67 DOP1B | 1.63e-04 | 610 | 168 | 13 | M3854 |
| Coexpression | LI_WILMS_TUMOR_ANAPLASTIC_UP | 1.65e-04 | 17 | 168 | 3 | M1215 | |
| Coexpression | CHANGOLKAR_H2AFY_TARGETS_DN | 1.65e-04 | 43 | 168 | 4 | MM902 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR | 1.73e-04 | 127 | 168 | 6 | M2608 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | EPRS1 MYH1 AFF2 ANK3 RPN2 MYO10 RBBP8 MBP USP19 MSX2 EFNB1 MKI67 DOP1B | 1.77e-04 | 615 | 168 | 13 | M8673 |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 2.05e-04 | 131 | 168 | 6 | M40316 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 VPS11 WAPL MBP CPA3 BTAF1 REV3L PFN1 PARP14 ZC3H11A UBR5 DIAPH1 SECISBP2 BOD1L1 CKAP2 BUB3 SPEN GIMAP6 XRCC6 PCM1 NUP153 PSD4 | 2.30e-04 | 1492 | 168 | 22 | M40023 |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN | 2.31e-04 | 134 | 168 | 6 | M8174 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL | 2.74e-04 | 327 | 168 | 9 | M4008 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | EPRS1 WAPL NAA15 RBBP8 GTSE1 CLIC4 PTPN14 ANLN MKI67 UBA6 PRKDC CKAP2 BUB3 | 2.76e-04 | 644 | 168 | 13 | M10501 |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN | 2.81e-04 | 196 | 168 | 7 | M6160 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP | 2.81e-04 | 196 | 168 | 7 | M7973 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 2.81e-04 | 196 | 168 | 7 | M9243 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 2.99e-04 | 198 | 168 | 7 | M9534 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 2.99e-04 | 198 | 168 | 7 | M8628 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 2.99e-04 | 198 | 168 | 7 | M3171 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | EPRS1 MYH1 AFF2 ANK3 RPN2 MYO10 RBBP8 MBP USP19 MSX2 EFNB1 MKI67 DOP1B | 3.02e-04 | 650 | 168 | 13 | MM1042 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 3.04e-04 | 141 | 168 | 6 | M39235 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RALGAPA1 EPRS1 VPS11 WAPL WASHC2C ACACA BTAF1 TTC3 WASHC2A C2CD5 SLC15A2 UBR5 DIAPH1 RSRP1 ALCAM PRKDC BUB3 PCM1 RHOT1 | 3.07e-04 | 1215 | 168 | 19 | M41122 |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 3.09e-04 | 199 | 168 | 7 | M6632 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN | 3.18e-04 | 200 | 168 | 7 | M9373 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP | 3.18e-04 | 200 | 168 | 7 | M4584 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN | 3.18e-04 | 200 | 168 | 7 | M8257 | |
| Coexpression | GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP | 3.18e-04 | 200 | 168 | 7 | M3663 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 3.18e-04 | 200 | 168 | 7 | M7447 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | EPRS1 MYH1 AFF2 ANK3 RPN2 MYO10 RBBP8 MBP USP19 MSX2 EFNB1 MKI67 DOP1B | 3.44e-04 | 659 | 168 | 13 | MM1040 |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 3.64e-04 | 22 | 168 | 3 | M40074 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NID2 COL12A1 MOSPD2 MYO1C MYO10 LIN54 PSD3 TNS2 BTAF1 PARP14 CEMIP2 DST EFNB1 ARID5B GIMAP6 | 4.15e-04 | 854 | 168 | 15 | M1533 |
| Coexpression | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN | 4.17e-04 | 23 | 168 | 3 | M18912 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | BRIP1 MOSPD2 ANK3 RBBP8 CARMIL1 CD2AP MBP CLASP2 PARP14 MSX2 MET FANCB FREM2 SERPINB5 DST SLC15A2 CLMN CCDC68 NR3C2 | 9.91e-06 | 780 | 164 | 19 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.48e-05 | 186 | 164 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.44e-05 | 152 | 164 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | NID2 BRIP1 WAPL NAA15 CEP192 C2CD5 FANCB BRDT UBR5 ANLN CCDC138 DIAPH1 UTP20 PRKDC NUP93 CKAP2 XRCC6 RAD54L | 6.90e-05 | 822 | 164 | 18 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | BRIP1 CEP192 C2CD5 FANCB BRDT ANLN DIAPH1 PRKDC NUP93 CKAP2 XRCC6 RAD54L | 7.80e-05 | 406 | 164 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | ZDHHC2 CDCA3 BRIP1 RBBP8 EOMES FANCB ANLN DNAJC15 MKI67 ALCAM CKAP2 RAD54L | 8.56e-05 | 410 | 164 | 12 | GSM538387_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | CDCA3 NID2 BRIP1 WAPL CEP192 C2CD5 UBR5 ANLN CCDC138 DIAPH1 UTP20 PRKDC NUP93 CKAP2 XRCC6 NUP153 RAD54L | 1.19e-04 | 781 | 164 | 17 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | NID2 BRIP1 WAPL CEP192 C2CD5 FANCB BRDT UBR5 ANLN CCDC138 UTP20 PRKDC NUP93 CKAP2 XRCC6 NUP153 RAD54L | 1.47e-04 | 795 | 164 | 17 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | CDCA3 NID2 BRIP1 WAPL CEP192 CEMIP2 C2CD5 FANCB UBR5 ANLN CCDC138 DIAPH1 UTP20 NUP93 CKAP2 XRCC6 RAD54L | 1.56e-04 | 799 | 164 | 17 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 1.66e-04 | 105 | 164 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | BRIP1 FANCB BRDT ANLN CCDC138 UBA6 PRKDC NUP93 CKAP2 XRCC6 RAD54L | 2.09e-04 | 385 | 164 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.23e-04 | 71 | 164 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ZDHHC2 EPRS1 WAPL RBBP8 THUMPD3 BTAF1 CEP192 TTC3 UBR5 ANLN UBA6 PRKDC FKBP3 | 2.59e-04 | 532 | 164 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 2.60e-04 | 114 | 164 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | BRIP1 CEP192 BRDT UBR5 CCDC138 UTP20 PRKDC NUP93 CKAP2 XRCC6 RAD54L | 2.66e-04 | 396 | 164 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.74e-04 | 333 | 164 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | CDCA3 BRIP1 GTSE1 CEP128 ANLN CCDC138 MKI67 QSER1 CKAP2 XRCC6 RAD54L | 2.77e-04 | 398 | 164 | 11 | GSM399397_500 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CDCA3 BRIP1 GTSE1 CEP192 CEP128 ANLN CCDC138 MKI67 CEP295 CKAP2 RAD54L | 2.04e-10 | 193 | 168 | 11 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CDCA3 BRIP1 ELOA2 GTSE1 CEP128 FANCB ANLN MKI67 CKAP2 RAD54L | 1.78e-09 | 180 | 168 | 10 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.25e-09 | 197 | 168 | 10 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-08 | 175 | 168 | 9 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-08 | 178 | 168 | 9 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.80e-08 | 179 | 168 | 9 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-08 | 183 | 168 | 9 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.72e-08 | 185 | 168 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.90e-08 | 186 | 168 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-08 | 187 | 168 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.28e-08 | 188 | 168 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-08 | 190 | 168 | 9 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.68e-08 | 190 | 168 | 9 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.68e-08 | 190 | 168 | 9 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.68e-08 | 190 | 168 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.60e-08 | 194 | 168 | 9 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.85e-08 | 195 | 168 | 9 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.85e-08 | 195 | 168 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-08 | 195 | 168 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.12e-08 | 196 | 168 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.12e-08 | 196 | 168 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.12e-08 | 196 | 168 | 9 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.39e-08 | 197 | 168 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.39e-08 | 197 | 168 | 9 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 6.67e-08 | 198 | 168 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-08 | 198 | 168 | 9 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 6.97e-08 | 199 | 168 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.97e-08 | 199 | 168 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 6.97e-08 | 199 | 168 | 9 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-08 | 200 | 168 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.02e-07 | 149 | 168 | 8 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.38e-07 | 155 | 168 | 8 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-07 | 169 | 168 | 8 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 170 | 168 | 8 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.93e-07 | 171 | 168 | 8 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-07 | 174 | 168 | 8 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 3.49e-07 | 175 | 168 | 8 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-07 | 177 | 168 | 8 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-07 | 178 | 168 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.15e-07 | 179 | 168 | 8 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-07 | 179 | 168 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-07 | 180 | 168 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.51e-07 | 181 | 168 | 8 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.11e-07 | 184 | 168 | 8 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-07 | 185 | 168 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-07 | 185 | 168 | 8 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.55e-07 | 186 | 168 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.78e-07 | 187 | 168 | 8 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-07 | 189 | 168 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 191 | 168 | 8 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-07 | 191 | 168 | 8 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 191 | 168 | 8 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.05e-07 | 192 | 168 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.05e-07 | 192 | 168 | 8 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.05e-07 | 192 | 168 | 8 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.34e-07 | 193 | 168 | 8 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.34e-07 | 193 | 168 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.63e-07 | 194 | 168 | 8 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.63e-07 | 194 | 168 | 8 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.63e-07 | 194 | 168 | 8 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.63e-07 | 194 | 168 | 8 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.63e-07 | 194 | 168 | 8 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.63e-07 | 194 | 168 | 8 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.63e-07 | 194 | 168 | 8 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.63e-07 | 194 | 168 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.93e-07 | 195 | 168 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-07 | 195 | 168 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.56e-07 | 197 | 168 | 8 | 1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-07 | 197 | 168 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-07 | 197 | 168 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-07 | 197 | 168 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-07 | 197 | 168 | 8 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-07 | 197 | 168 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.89e-07 | 198 | 168 | 8 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 198 | 168 | 8 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 168 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.59e-07 | 200 | 168 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 9.59e-07 | 200 | 168 | 8 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 9.59e-07 | 200 | 168 | 8 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.59e-07 | 200 | 168 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Severe-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-06 | 140 | 168 | 7 | 683ee5e103f0c68cbbec019249404d381dbc39f3 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.22e-06 | 143 | 168 | 7 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.83e-06 | 152 | 168 | 7 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 157 | 168 | 7 | 1ccb07a38d3fb606ee5fbc0437655f49baaaa62c | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.47e-06 | 159 | 168 | 7 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 163 | 168 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-06 | 163 | 168 | 7 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-06 | 166 | 168 | 7 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-06 | 167 | 168 | 7 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.42e-06 | 167 | 168 | 7 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-06 | 167 | 168 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.70e-06 | 169 | 168 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.85e-06 | 170 | 168 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 171 | 168 | 7 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-06 | 172 | 168 | 7 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| Drug | torcetrapib | EHBP1 NAA15 AFF2 ANK3 THUMPD3 CDK14 TTC3 PTPN14 DST UBA6 BOD1L1 NR3C2 PCM1 | 1.45e-06 | 342 | 166 | 13 | ctd:C483909 |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 6.89e-06 | 179 | 166 | 9 | 4585_DN | |
| Drug | Apa-sg | 9.70e-06 | 19 | 166 | 4 | CID000126348 | |
| Drug | Methamphetamine | RALGAPA1 CDCA3 VPS11 FMO3 WASHC2C LIN54 MBP PSD3 TNS2 CLIC4 TACC2 BTAF1 ABCC6 TOE1 TH ZC3H11A DST EFNB1 KLHL15 MKI67 SECISBP2 CKAP2 CSMD1 TNS1 RAD54L ZMYND12 | 1.03e-05 | 1401 | 166 | 26 | ctd:D008694 |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.21e-05 | 192 | 166 | 9 | 4104_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.32e-05 | 194 | 166 | 9 | 4312_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 6026_DN | |
| Drug | geldanamycin | EHBP1 EPRS1 COL12A1 CDK14 TTC3 MET NBAS FANCB ZC3H11A DST BOD1L1 PCM1 | 1.88e-05 | 371 | 166 | 12 | ctd:C001277 |
| Drug | chrysene | EHBP1 MYH1 ANK3 CEP162 CARMIL1 GPATCH1 MUC16 TACC2 CDK14 SERPINB5 SERPINB10 EFNB1 ADAMDEC1 UBR5 MKI67 RSRP1 CKAP2 FKBP3 ADGRD1 | 2.09e-05 | 871 | 166 | 19 | ctd:C031180 |
| Disease | Malignant neoplasm of breast | EHBP1 MYH1 NID2 BRIP1 CD109 TACC2 TTC3 EOMES MRPS7 EEF2 SERPINB5 ZC3H11A PTPN14 MKI67 UTP20 BOD1L1 SPEN TNS1 RAD54L | 8.22e-06 | 1074 | 163 | 19 | C0006142 |
| Disease | urate measurement, bone density | CARMIL1 ABCB5 LIN54 CD2AP PSD3 CLASP2 FSIP2 ARID5B DIAPH1 NR3C2 PRKDC NUP153 DNAH11 | 4.29e-05 | 619 | 163 | 13 | EFO_0003923, EFO_0004531 |
| Disease | pro-hydroxy-pro measurement | 8.79e-05 | 16 | 163 | 3 | EFO_0021132 | |
| Disease | DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder) | 9.07e-05 | 3 | 163 | 2 | C1852282 | |
| Disease | Liver carcinoma | ZDHHC2 CDCA3 ACACA GTSE1 CDK14 MET TH ANLN MKI67 CSMD1 RAD54L | 1.27e-04 | 507 | 163 | 11 | C2239176 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TACC2 BTAF1 REV3L CDK14 RYR2 CEMIP2 MET NRXN3 ARID5B PLEKHA5 ZFHX3 ALCAM PRKDC HPS5 | 1.53e-04 | 801 | 163 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | CD166 antigen measurement | 1.81e-04 | 4 | 163 | 2 | EFO_0020245 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 6.02e-04 | 30 | 163 | 3 | C1868672 | |
| Disease | common variable immunodeficiency | 6.25e-04 | 7 | 163 | 2 | MONDO_0015517 | |
| Disease | mucocutaneous lymph node syndrome | 8.45e-04 | 76 | 163 | 4 | EFO_0004246 | |
| Disease | cleft lip | 1.06e-03 | 284 | 163 | 7 | EFO_0003959 | |
| Disease | pyoderma gangrenosum | 1.06e-03 | 9 | 163 | 2 | EFO_0006835 | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.11e-03 | 140 | 163 | 5 | EFO_0001357 | |
| Disease | metabolite measurement | 1.16e-03 | 560 | 163 | 10 | EFO_0004725 | |
| Disease | diastolic blood pressure, systolic blood pressure | BRIP1 ANK3 CARMIL1 DNAH2 RYR2 MET ARID5B ZFHX3 NR3C2 CLEC16A PCM1 | 1.30e-03 | 670 | 163 | 11 | EFO_0006335, EFO_0006336 |
| Disease | bone quantitative ultrasound measurement | 1.31e-03 | 39 | 163 | 3 | EFO_0004514 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.33e-03 | 10 | 163 | 2 | cv:CN327126 | |
| Disease | lactose measurement | 1.33e-03 | 10 | 163 | 2 | EFO_0010507 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Focal segmental glomerulosclerosis | 1.33e-03 | 10 | 163 | 2 | cv:C0017668 | |
| Disease | glucagon-like peptide-1 measurement | 1.33e-03 | 10 | 163 | 2 | EFO_0008465 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | cancer antigen 125 measurement | 1.33e-03 | 10 | 163 | 2 | EFO_0010603 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement | EHBP1 COL12A1 WAPL ACACA DNAH2 NBAS NRXN3 MMEL1 ZNF608 BRDT RALGPS1 ARID5B ZFHX3 NR3C2 CSMD1 CLEC16A | 1.48e-03 | 1242 | 163 | 16 | EFO_0007878 |
| Disease | eye color | 1.59e-03 | 90 | 163 | 4 | EFO_0003949 | |
| Disease | chemotherapy-induced alopecia, response to antimicrotubule agent | 1.61e-03 | 11 | 163 | 2 | EFO_0005260, EFO_0005400 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 1.61e-03 | 11 | 163 | 2 | cv:CN043612 | |
| Disease | Copper-Overload Cirrhosis | 1.61e-03 | 11 | 163 | 2 | C1876165 | |
| Disease | interleukin-6 measurement, response to stimulus | 1.61e-03 | 11 | 163 | 2 | EFO_0004810, GO_0050896 | |
| Disease | metabolite measurement, body weight gain | 1.93e-03 | 12 | 163 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 2.11e-03 | 46 | 163 | 3 | EFO_0008003, GO_0097332 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 2.11e-03 | 46 | 163 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Neuroblastoma | 2.25e-03 | 47 | 163 | 3 | C0027819 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 2.27e-03 | 13 | 163 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.27e-03 | 13 | 163 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 2.27e-03 | 13 | 163 | 2 | cv:C4273714 | |
| Disease | pancreatic cancer (is_marker_for) | 2.42e-03 | 101 | 163 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Weight Gain | 2.51e-03 | 102 | 163 | 4 | C0043094 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.53e-03 | 169 | 163 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Fanconi anemia | 2.64e-03 | 14 | 163 | 2 | cv:C0015625 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.04e-03 | 15 | 163 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | ANK3 CEP162 CPA3 RFTN2 MSX2 TBC1D22A RALGPS1 ZFHX3 NR3C2 ALCAM QSER1 FAM124B TNS1 XRCC6 RHOT1 DNAH11 | 3.27e-03 | 1345 | 163 | 16 | EFO_0010736 |
| Disease | neuritic plaque measurement | 3.37e-03 | 349 | 163 | 7 | EFO_0006798 | |
| Disease | amygdala volume change measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0021490 | |
| Disease | 4-acetamidobutanoate measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0021003 | |
| Disease | response to hydrochlorothiazide, systolic blood pressure change measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0005202, EFO_0006944 | |
| Disease | Intellectual Disability | 3.52e-03 | 447 | 163 | 8 | C3714756 | |
| Disease | pneumonia, COVID-19 | 3.62e-03 | 113 | 163 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | Benign neoplasm of stomach | 3.91e-03 | 17 | 163 | 2 | C0153943 | |
| Disease | erythrocyte cadmium measurement | 3.91e-03 | 17 | 163 | 2 | EFO_0007807 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.91e-03 | 17 | 163 | 2 | C0496905 | |
| Disease | theta wave measurement | 3.91e-03 | 17 | 163 | 2 | EFO_0006873 | |
| Disease | Carcinoma in situ of stomach | 3.91e-03 | 17 | 163 | 2 | C0154060 | |
| Disease | Bone marrow hypocellularity | 4.38e-03 | 18 | 163 | 2 | C1855710 | |
| Disease | facial asymmetry measurement | 4.88e-03 | 19 | 163 | 2 | EFO_0009751 | |
| Disease | hip bone mineral density | 5.33e-03 | 126 | 163 | 4 | EFO_0007702 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.39e-03 | 64 | 163 | 3 | DOID:4947 (is_marker_for) | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 5.40e-03 | 20 | 163 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | Craniosynostosis | 5.40e-03 | 20 | 163 | 2 | C0010278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPQSKDSTSVQDFSK | 116 | Q9HBT8 | |
| SPTVFSEDQLSKEKV | 596 | O95936 | |
| VFSVTTVDLKRKPAD | 51 | Q9Y696 | |
| PFITFNSEVKTDVNK | 76 | Q9Y696 | |
| SFTKRTVAPDSASNK | 1061 | Q6ZU80 | |
| TNLKPTEAKAVRFDT | 3541 | Q96PZ7 | |
| KKQPFEESTRNTEDS | 291 | Q99708 | |
| PDFQRVTTTENTIKE | 396 | Q68DQ2 | |
| SATEKVFKQQEIPSV | 166 | Q58F21 | |
| VKRKADTTTPATSAV | 211 | Q58F21 | |
| AEFSVAKILPKTVNS | 381 | Q6QNK2 | |
| LPVNVTAFTSKKVSD | 1516 | Q8IZF6 | |
| QVIDKKPSIDNFSTA | 361 | Q2M3G0 | |
| NDPTTRASTKSVSFK | 406 | P51816 | |
| TATKPKRQTAVTAVE | 831 | P51816 | |
| RQTAKKARVEEASTP | 51 | P54259 | |
| VKTLIKSFDSASQVP | 841 | Q69YQ0 | |
| FAKATPVDRQETKQT | 4461 | Q96DT5 | |
| RKKIDSQRDFTVASP | 91 | Q13085 | |
| IFIRQVTDAETKPKS | 311 | O43684 | |
| PEDKKVRVQRTQSTF | 66 | O94921 | |
| PKSVDFDSLTVRTSK | 456 | Q9Y5K6 | |
| VPEKISTSTFQRQAE | 161 | Q9P1Z9 | |
| KTQVALSSETPRTKV | 296 | Q9H2F9 | |
| SKNSETFPTILEEAK | 1251 | O60610 | |
| RKNPTTEETVLTKTS | 571 | Q8WWL7 | |
| QKNPEEFKTSVSLAV | 216 | O94973 | |
| SKQVFSKEEARQPTE | 146 | Q99618 | |
| STTEDILFQKDKSTP | 231 | Q8TBY9 | |
| FRKPLQVKDESSAAT | 191 | Q8WWK9 | |
| FTSDTKPIINKVASV | 601 | Q8N1F7 | |
| TTTKSAQEFAVDPEK | 1651 | Q2KHR3 | |
| TPRKRKSSSETQIQE | 31 | Q92698 | |
| STLKRPQVETKTEFA | 21 | Q52LD8 | |
| LSVVESKSATFPSEK | 351 | Q5JS13 | |
| ETKESTSCPVVQKRA | 571 | Q9H8H0 | |
| EIPRVFTSSIKTKSA | 5251 | Q8WXI7 | |
| SVAKTPYDTSRRQEK | 646 | Q8IYF1 | |
| IVSVKPNVKEFTETS | 296 | P31513 | |
| PIKASSSKVSSQRAE | 331 | Q8IZA3 | |
| TITKADSNTTVKPAF | 81 | Q6MZP7 | |
| KINSDSSFSVPIKQE | 416 | P08235 | |
| TRRKKNVTESPSFSA | 536 | P20916 | |
| ARVRTQFADSKKTPS | 7476 | Q03001 | |
| PSKKRCSDNTEVEVS | 66 | Q9NQW6 | |
| LKTNPKEFIEAVSRT | 1251 | Q9Y3R5 | |
| ERVKVKTESQDPTSS | 181 | Q2LD37 | |
| TFRISISDVDNKKPV | 1521 | Q5SZK8 | |
| KIVDKAQPETQATSF | 2951 | Q5SZK8 | |
| AVKESVSSFVRKTTE | 541 | Q9UPZ3 | |
| RKPKSATDSVDVQSI | 1381 | Q5CZC0 | |
| RSSVEDTVKNSEPTK | 3211 | Q5CZC0 | |
| VKSSSVSPFERQRTK | 3936 | Q5CZC0 | |
| PKASTIFLRKSQTDV | 86 | Q5T2Q4 | |
| APKAIVTTDDFASKT | 106 | Q9BRR8 | |
| AQTEEPVQAKVFSRK | 1336 | Q15154 | |
| TADAPSKDIFVKLTT | 561 | Q8IXI2 | |
| AEPKESFVKGTIQSR | 41 | Q9UKX2 | |
| TVTQDRTKNIEKSPT | 286 | A6NFA0 | |
| RNIIADPVTFKTKSS | 866 | Q9Y4C0 | |
| VSSSPVQRQSEEKEF | 721 | Q96LU7 | |
| KARISQSTKTFTPCE | 1861 | Q9HD67 | |
| STKSVQADRKILPFT | 356 | O95447 | |
| VDPKESFVKATVQSR | 41 | P12882 | |
| SEVNSKPRKERTAFT | 181 | P50222 | |
| VTSFLESKTKPVSSR | 286 | Q96KJ4 | |
| RETAKQKLDPAASVT | 2161 | P46013 | |
| VQVKEEPSAVKFTQT | 2731 | P46013 | |
| NSTAKDRPAVEKART | 156 | Q495T6 | |
| VDAVTFSPKAVTKLS | 1896 | A2RRP1 | |
| SSAPREVQKAEESKV | 456 | Q3BBV0 | |
| SKSTATEVAREEAKP | 601 | Q9NYZ3 | |
| LEEFRKTQQTSPDKV | 171 | Q9BXJ9 | |
| RVTLTPDSKKEESFV | 551 | Q8NB91 | |
| EKIVISRSTSPTFNK | 981 | Q9BX63 | |
| SIDVSFQSKVDTKPL | 341 | Q14112 | |
| FQSKVDTKPLEESST | 346 | Q14112 | |
| AEAVKTVFKATLPDT | 971 | Q460N5 | |
| TKTTESPLAKVNRDQ | 151 | Q5W5W9 | |
| AESSEPERKRQKSVS | 2961 | Q8NFC6 | |
| KPSLNFTATVKVTRA | 361 | Q6YHK3 | |
| SVDPKESSVLQFKVQ | 196 | Q9H5Z6 | |
| KSSRIRSAKPQTTVF | 271 | Q96M94 | |
| APESEKETKAVTNFI | 276 | P15088 | |
| FKEIEKVALPTNTTS | 126 | Q96M89 | |
| PEFKTTAEKLAVQNS | 1591 | O14981 | |
| PRNLKVTDETTDSFK | 726 | Q99715 | |
| QVITETAKKISTPSF | 66 | Q9Y5T4 | |
| TFPTRQKKETDERQA | 1256 | Q5JV73 | |
| DKEKRAAVDISTSFP | 41 | Q9HC77 | |
| VFSETSPILTEKQAK | 16 | Q0P5P2 | |
| LTTSRPSKEADNTVK | 176 | P98172 | |
| RFKGTESISKVSEQV | 71 | Q00688 | |
| EEAVLKFRQKPSSIS | 356 | Q5T5S1 | |
| AAATNTSKVDPKLRT | 3706 | Q12955 | |
| PKSQASAKFTSIRRE | 41 | Q9UHN6 | |
| TRKKSENPTETDSCI | 581 | Q5TB80 | |
| RNPVVFSKDSTVRKT | 1001 | Q8NDI1 | |
| DTAVTDSKRTADPKN | 61 | P02686 | |
| KVEIRNKSITFPTTE | 2271 | Q8TEP8 | |
| IFAVSKDTSKAARVP | 606 | Q8NEP3 | |
| ASTEKISIPRTFVKN | 806 | Q5VZK9 | |
| KKSDPVVSYRETVSE | 571 | P13639 | |
| TPCTEKIRFSVSKDV | 271 | Q66K89 | |
| EKRLSSTQVKQDTSP | 1781 | Q8NDH2 | |
| ERTQKSFPTKSNDTL | 1561 | Q9C0D2 | |
| PETSAKTTIVNFAVK | 3496 | Q9P225 | |
| KNESKETLFSPVSIE | 6 | Q16348 | |
| KELPTRSSSENAKVT | 4531 | Q92736 | |
| RSSTKKSVQYDDVPE | 71 | Q13740 | |
| KTPVEKSLQRASTDN | 806 | Q86YS7 | |
| KRASTAKQVSSVPFL | 26 | Q8N9Y4 | |
| VKPFETASVKSENSE | 96 | P35548 | |
| TPAQTISTEFAVKLK | 711 | P08581 | |
| TKNIVAFKVRTTAPE | 356 | Q8NHP6 | |
| NRTPSATLSEKISKE | 341 | Q5VWG9 | |
| RKVSKLAVSAQSEPA | 2246 | O75691 | |
| KTSSVFEDPVISKFT | 81 | Q9Y2R9 | |
| VEATKNETSAPFKER | 721 | P07814 | |
| STARKTIPKEQVSSA | 176 | Q7Z5M5 | |
| APTFNVTVTKTDKTL | 96 | P07737 | |
| FESKLSTRPVTKTSQ | 66 | Q6P9H5 | |
| IKSVPEKDRTTSEAQ | 891 | O95255 | |
| QASKVEKVFFTTAVP | 591 | Q14872 | |
| ESKDFRPNKVSETSR | 451 | Q9HDB5 | |
| SQVVDTVVKVFSAKP | 361 | Q92786 | |
| KLSKPRVTFSEESAV | 151 | Q5JXC2 | |
| DEAPTTAKVKRNISE | 1026 | Q8NDX1 | |
| KVQLSVKTFQEDSSP | 601 | Q15678 | |
| ETIKSPTDTQKRVSV | 1241 | Q5VXU9 | |
| AKNVSTSKPEFEFTT | 206 | Q96T21 | |
| SESETKECPFRVNKT | 176 | P36952 | |
| KVSSQPEKRVSFSLE | 2481 | Q9P2P6 | |
| TIESVDFQKNPEKSR | 141 | Q96P63 | |
| ATEEASSRSPKIDQK | 266 | Q9BUV0 | |
| KIKVVPSASTTFDNF | 276 | O15204 | |
| QSFRSKPSEERKTIN | 756 | Q14865 | |
| FVRIKETPSEQESKV | 311 | Q96JQ2 | |
| DSKPSKNVARSAAVE | 961 | Q2KHT3 | |
| TTEPKSSDVRKAAQI | 1031 | Q7Z460 | |
| EPKSSDVRKAAQSVL | 831 | O75122 | |
| NEPIRDAKKSTSAET | 856 | P63136 | |
| VKTPKTVFFESLERQ | 291 | A0AVT1 | |
| ETNEPVKTKTRTFNT | 291 | P12956 | |
| PARAFSAVKVKISSN | 331 | Q8TC36 | |
| PIKFLVSVSKENSTA | 696 | O94966 | |
| FTPTSREKETRNTLK | 336 | A4D1E1 | |
| VSRDRKVSPKSEFTS | 286 | Q9H270 | |
| FNNPTTKTADDETRK | 321 | Q70EL2 | |
| KPSADQKRSVTFIEA | 3101 | Q8N2C7 | |
| SERSSKLQPVTEVKT | 1481 | Q6GYQ0 | |
| SKRSKTPVQAAAVSI | 1821 | Q96T58 | |
| ESKKSVDLQTFPSSR | 1301 | O60673 | |
| STVDKDQSIAPKTTR | 381 | P04844 | |
| RLPTKSSQKVEVETS | 611 | O75152 | |
| SPETRAKVKFVQDTS | 1446 | Q9HBL0 | |
| DVKAKPVSDNSSRQV | 1251 | P53804 | |
| KADIATSKTTTRFRP | 401 | Q7Z5K2 | |
| SKTRKVQSTADIFGD | 471 | Q9Y4E1 | |
| FKEKAVASPEATVSQ | 491 | Q9Y4E1 | |
| VNTRRKSTDSVPISK | 2066 | O95359 | |
| KFSSPIVKSTEANVL | 526 | P49790 | |
| LPQRKTEVVSSSAKS | 1136 | Q96JH7 | |
| TPVKAKRVSTFQEFE | 51 | Q8WUA7 | |
| ETVTSFRKRESKVPA | 3866 | P78527 | |
| ESTSDKAPQKTIFVL | 296 | Q9H0C1 | |
| SKEETEPQVLKFRVT | 216 | Q9BV44 | |
| FKEKAVASPEATVSQ | 491 | Q641Q2 | |
| AAEDIKASPSSTNKR | 486 | Q9ULD9 | |
| VSKNKSTLEAFRSPV | 236 | Q9UIJ5 | |
| RVDKITSENAPTKET | 276 | Q9HAU0 | |
| LQRTASPDSKESSKV | 326 | Q9NYI0 | |
| SREKKESFPLTVTSA | 86 | A0A075B6N1 | |
| NTTEKPFRINETTSK | 201 | P48595 | |
| KAVPLTVAKSQFSRS | 481 | Q96GM8 | |
| ASVEFVFSSSPEKIK | 416 | Q63HR2 | |
| KVAESKDQVFQPSTV | 21 | A0A0B4J234 | |
| TEPSVVESKDRKANA | 1071 | O95071 | |
| QAEKELTDSPATSKR | 1181 | Q15911 | |
| ATKPSALSRAVKVFE | 121 | P07101 | |
| KINRSLASKDVESPS | 396 | O00159 | |
| LDKDTTTATTTPRQK | 1121 | Q9NR99 |